Search

everythinglearnresearchcommunity

for

Search:↓

Daughters of women with PCOS generally experience normal puberty but may have more body hair and different body fat distribution.

The PCOS-specific questionnaire needs more work to fully measure quality of life in clinical trials.

Finasteride use doesn't cause sexual dysfunction in men with hair loss.

Hydroxychloroquine showed some potential, but overall, the three drugs had limited success in treating lupus in dogs.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Single-cell engineered biotherapeutics show promise for skin treatment but need more research and trials.

New male hormonal contraceptives show promise but need more research on long-term effects and funding for larger trials.

Certain spices may help prevent and treat skin cancer, but more human trials are needed.

Low-Level Light Therapy (LLLT) is a safe and effective method for skin rejuvenation, acne treatment, wound healing, body contouring, and hair growth, but more well-designed trials are needed for confirmation.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Losing 5-10% body weight can improve PCOS symptoms, letrozole is better than clomiphene for fertility, and managing weight and blood sugar is important to reduce pregnancy complications.

Finasteride reduces prostate cancer risk but may increase high-grade tumors and has side effects; biopsy methods have similar outcomes; psychosocial factors affect sexual recovery post-surgery.

Clinical trials for hair loss in the USA show differences in participation among different races and ethnic groups.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

Finasteride helps treat prostate issues and may prevent prostate cancer in high-risk men.

Antiandrogenic pretreatment for women with PCOS does not improve fertility outcomes and delays pregnancy.

Finasteride and dutasteride increase sexual dysfunction risk by 1.57 times in male hair loss treatment.

Baricitinib improves quality of life and reduces anxiety and depression in severe alopecia areata patients with hair regrowth.

Liposomal systems show promise for delivering drugs through the skin but face challenges like high costs and stability issues.

Regenerative pharmacology, which combines drugs with regenerative medicine, shows promise for repairing damaged body parts and needs more interdisciplinary research.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

Platelet-Rich Plasma (PRP), a protein-rich extract from a patient's blood, shows promise in improving hair density, thickness, and quality, but the best method of use and number of treatments needed for noticeable results are still unclear.

Herbal remedies might help with hair loss but need more research for safety and effectiveness.

Targeted immunotherapy could be a promising new treatment for hair regrowth.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

Methotrexate reduced the need for steroids in asthma patients without worsening their condition.

Oral and topical finasteride are effective and safe for treating female hair loss.

5-alpha-reductase inhibitors may cause a low incidence of erectile dysfunction that decreases over time.

Bimatoprost gel makes eyelashes grow longer, but may cause side effects and should be monitored by an eye doctor.